|
Originally published In Press as doi:10.1074/jbc.M800778200 on June 19, 2008
J. Biol. Chem., Vol. 283, Issue 36, 24659-24672, September 5, 2008
Cholesterol-dependent Separation of the β2-Adrenergic Receptor from Its Partners Determines Signaling EfficacyINSIGHT INTO NANOSCALE ORGANIZATION OF SIGNAL TRANSDUCTION*
Stéphanie M. Pontier12,
Yann Percherancier13,
Ségolène Galandrin,
Andreas Breit,
Céline Galés, and
Michel Bouvier, Holds a Canada Research Chair in Signal Transduction and Molecular Pharmacology4
From the
Institut de Recherche en Immunologie et Cancérologie, Département de Biochimie, and Groupe de Recherche Universitaire sur le Médicament, Université de Montréal, Montréal, Québec H3C 3J7, Canada
Determining the role of lipid raft nanodomains in G protein-coupled receptor signaling remains fraught by the lack of assays directly monitoring rafts in native membranes. We thus combined extensive biochemical and pharmacological approaches to a nanoscale strategy based on bioluminescence resonance energy transfer (BRET) to assess the spatial and functional influence of cholesterol-rich liquid-ordered lipid nanodomains on β2 adrenergic receptor (β2AR) signaling. The data revealed that whereas β2AR did not partition within liquid-ordered lipid phase, a pool of G protein and adenylyl cyclase (AC) were sequestered in these domains. Destabilization of the liquid-ordered phase by cholesterol depletion led to a lateral redistribution of G s and AC that favored interactions between the receptor and its signaling partners as assessed by BRET. This resulted in an increased basal and agonist-promoted β2AR-stimulated cAMP production that was partially dampened as a result of constitutive protein kinase A-dependent phosphorylation and desensitization of the receptor. This restraining influence of nanodomains on β2AR signaling was further substantiated by showing that liquid-ordered lipid phase stabilization using caveolin overexpression or increasing membrane cholesterol amount led to an inhibition of β2AR-associated signaling. Given the emerging concept that clustering of receptors and effectors into signaling platforms contributes to the efficacy and selectivity of signal transduction, our results support a model whereby cholesterol-promoted liquid-ordered lipid phase-embedding Gs and AC allows their lateral separation from the receptor, thus restraining the basal activity and controlling responsiveness of β2AR signaling machinery within larger signaling platforms.
Received for publication, January 30, 2008
, and in revised form, June 10, 2008.
* This work was supported by grants from the Canadian Institute for Health Research (CIHR) and the Heart and Stroke Foundation of Canada (to M. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1 and S2.
1 Both authors contributed equally to this work.
2 Current address: Molecular Oncology Group, McGill University, Royal Victoria Hospital, Room H5.21, 687 Pine Ave. West, Montreal, Quebec H3A 1A1, Canada.
3 Recipient of a fellowship from the Institut National de la Santé etdela Recherche Médicale (INSERM, France) and a postdoctoral fellowship from the CIHR. Current address: CNRS FRE 2944, Institut Lwoff, 7 rue Guy Moquet, 94801 Villejuif, France.
4 To whom correspondence should be addressed: Institut de Recherche en Immunologie et Cancérologie, Université de Montréal, C.P. 6128 Succursale Centre-ville, Montréal, Québec H3C 3J7, Canada. Tel.: 514-343-6319; Fax: 514-343-6843; E-mail: michel.bouvier{at}umontreal.ca.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Orcel, L. Albizu, S. Perkovska, T. Durroux, C. Mendre, H. Ansanay, B. Mouillac, and A. Rabie
Differential Coupling of the Vasopressin V1b Receptor through Compartmentalization within the Plasma Membrane
Mol. Pharmacol.,
March 1, 2009;
75(3):
637 - 647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Halls, E. T. van der Westhuizen, J. D. Wade, B. A. Evans, R. A. D. Bathgate, and R. J. Summers
Relaxin Family Peptide Receptor (RXFP1) Coupling to G{alpha}i3 Involves the C-Terminal Arg752 and Localization within Membrane Raft Microdomains
Mol. Pharmacol.,
February 1, 2009;
75(2):
415 - 428.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|